PIMPINELLA PIMPINELLA SAXIFRAGA

PIMPINELLA (Pimpinella saxifraga L.) ++

KOM treats P. saxifraga L. and P. major (L.) Huds. as one. PHR and PH2 call it just P. major, not covering P. saxifraga. HHB treats both, admitting that there is a H. saxifraga var. maior, giving uses as though they were interchangeable. HH2 treats them as two distinct species. I treat them as an aggregate, although still maintaining the HDR entries as separate.

Activities (Pimpinella) :
Antispasmodic (f; MAD); Diuretic (f; MAD); Emmenagogue (f; HHB); Expectorant (f; HHB; PH2); Lactagogue (f; MAD); Secretolytic (2; PHR); Secretomotor (2; PHR); Vermifuge (f; HHB); Vulnerary (f; MAD).

Indications (Pimpinella) :
Angina (f; HHB; MAD); Asthma (f; HHB); Backache (f; PH2); Bacteria (f; PH2); Bladder Stone (f; MAD; PHR); Bronchosis (2; HHB; PHR); Cardiopathy (f; MAD); Catarrh (2; KOM; PH2); Chill (f; PHR; PH2); Cholecystosis (f; PHR); Cold (f; PHR; PH2); Colic (f; MAD); Cough (2; PHR; PH2); Cramp (f; MAD); Croup (f; HHB); Cystosis (f; MAD; PH2); Diphtheria (f; MAD); Dyslactea (f; MAD); Dysuria (f; PHR); Eczema (f; MAD); Edema (f; PHR; PH2); Enterosis (f; PH2); Epistaxis (f; HHB); Frostbite (f; HHB); Gastrosis (f; MAD; PH2); Gout (f; HHB; MAD); Headache (f; HHB); Hepatosis (f; MAD); Infection (f; PH2); Inflammation (f; PH2); Kidney Stone (f; MAD; PHR; PH2); Laryngosis (f; HHB); Mucososis (2; PHR); Nephrosis (f; MAD; PHR; PH2); Nervousness (f; MAD); Ophthalmia (f; MAD); Otosis (f; MAD); Pain (f; PH2); Palpitation (f; HHB); Pharyngosis (f; HHB; PHR; PH2); Phthisis (f; MAD); Plethora (f; MAD); Pulmonosis (f; PH2); Respirosis (2; KOM; MAD); Rhinosis (f; HHB); Sore Throat (f; HHB); Splenosis (f; MAD); Stomatosis (f; PHR; PH2); Stone (f; PH2); Uterosis (f; MAD); Varicosis (f; PHR; PH2); Worm (f; HHB); Wound (f; PHR).

Dosages (Pimpinella) :
0.5–10 g root (HHB); 6–12 g dry root (KOM); 6–12 (–15) g root tincture (1:5) (KOM; PH2); 10–15 drops root tincture (MAD); 1 tsp (4.6 g) herb in wine (MAD).

Contraindications, Interactions, and Side Effects (Pimpinella) :
Not covered (AHP). None known (KOM). “Hazards and/or side effects not known for proper therapeutic dosages” (PH2). Furanocoumarins may generate phototoxicity in fair-skinned people (PH2).